Inari Medical Faces Multiple Investigations Over Alleged Anti-Kickback Violations

The medical device company's stock plummeted following the disclosure of a federal investigation into potential violations of anti-kickback statutes.

• Inari Medical, Inc. is under investigation by the U.S. Department of Justice for potential violations of federal Anti-Kickback Statute and Civil False Claims Act.
• The investigations were prompted by the company's disclosure of a civil investigative demand related to payments to healthcare professionals.
• Following the disclosure, Inari Medical's stock fell $12.14 per share, or 20.8%, marking a significant impact on its market value.
• Several law firms, including Rosen Law Firm and Holzer & Holzer, LLC, are preparing or investigating potential securities claims on behalf of Inari Medical investors.
• Investors who purchased Inari Medical securities may be entitled to compensation, with law firms encouraging affected shareholders to join class action lawsuits.

3 Articles

Benzinga Benzinga Benzinga